The Centre for Law, Medicine and Life Sciences has appointed Dr John Liddicoat as a Senior Research Associate. Dr Liddicoat will work with Dr Kathy Liddell (Director of LML) to develop a flagship research project on the legal issues surrounding the re-purposing of pharmaceuticals.
The aim of the project is to harness legal expertise in the field of intellectual property to help scientists and clinicians with the challenge of re-purposing known drugs. In particular the project will study the role of law in making re-purposing research economically attractive, efficient and effective – what does the law do to help or hinder re-purposing of pharmaceuticals, and what could it do better? It also intends to build an evidence base for improving legal policy in this area.
This project will be LML's primary contribution to the Collaborative Research Program in Biomedical Innovation Law, headed by the University of Copenhagen. LML will also contribute to a sixth Synergy study. Other key collaborators include the Petrie Flom Center (Harvard), and the University of Michigan. The CeBIL Collaborative Project is supported by a grant from the Novo Nordisk Foundation
More about the CeBIL collaboration can be found here.